Mankind Pharma Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
MANKIND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mankind Pharma has informed the stock exchanges that its trading window is closed for designated persons and insiders, as required under SEBI's Prohibition of Insider Trading Regulations, 2015. During this period, company insiders — including directors, key managerial personnel, and their immediate relatives — are barred from trading in the company's shares. This is a routine compliance measure that is typically undertaken ahead of a board meeting or the announcement of financial results. The closure duration and the reason (such as quarterly results declaration) are not specified in the filing.
No direct impact on retail shareholders or stock price. However, the closure often signals that an important corporate announcement, such as quarterly earnings or a board decision, is likely forthcoming.